Drug intelligence / Profile preview

Bimin formula

Development stage
Unknown
Lead developer
Guangdong Provincial Hospital of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Bimin formula (also known as Bimin Fang) is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Guangdong Provincial Hospital of Chinese Medicine specifically for the treatment of allergic rhinitis. The formula is designed to address the TCM pattern of Lung-Spleen Qi Deficiency, which is frequently associated with chronic nasal allergies. It typically consists of a combination of several medicinal herbs, including *Astragalus membranaceus* (Huangqi), *Atractylodes macrocephala* (Baizhu), *Saposhnikovia divaricata* (Fangfeng), and *Magnolia biondii* (Xinyi). Mechanistically, Bimin formula acts as an immunomodulator that restores the Th1/Th2 cytokine balance. It has been shown to downregulate the Th2-mediated immune response, leading to a significant reduction in serum immunoglobulin E (IgE) levels and a decrease in the production of pro-inflammatory cytokines such as IL-4, IL-5, and IL-13. Clinical studies conducted in China have demonstrated its efficacy in alleviating hallmark symptoms of allergic rhinitis, including paroxysmal sneezing, rhinorrhea, and nasal congestion, often showing comparable results to standard antihistamines with a favorable safety profile.

Other names
Bimin FangBimin decoctionBimin Granules鼻敏方鼻敏颗粒鼻敏煎
02

Targets

NF-κBAQP5 (Aquaporin-5)

Beyond the preview

Go deeper on Bimin formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bimin formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call